Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure Trial

“Patients report benefit from [baroreflex activation therapy] in key domains of quality of life such as symptom control, return to key activities and aspects of peace of mind from baseline to the 2-year follow-up. These findings give information about expectation of benefit in terms of symptom relief and how long they could expect sustained benefit in the context of chronic heart failure. This information can be used in shared decision-making so that patients can consider if the benefits match what they want to achieve.”